Tracking tumor-specific CD8 T cell responses.

Trends in immunology
Authors
Abstract

In a recent article, Puig-Saus et al. computationally predict and experimentally validate neoantigen-specific T cell responses in patients with melanoma. They identify a restricted set of neoantigens recognized by polyclonal CD8 T cells as a unique feature of anti-PD-1 responders and engineer autologous tumor-responsive T cells expressing neoantigen-specific TCRs, providing proof-of-concept for future cellular therapies.

Year of Publication
2023
Journal
Trends in immunology
Volume
44
Issue
5
Pages
326-328
Date Published
05/2023
ISSN
1471-4981
DOI
10.1016/j.it.2023.03.012
PubMed ID
37031062
Links